Gene-Targeted blood pressure treatment shows promise for black patients
NCT ID NCT04840342
First seen Nov 06, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study looks at whether a treatment tailored to a specific gene (LSD1) can better control high blood pressure and protect the kidneys in Black adults who carry a certain risk version of that gene. About 300 participants will follow a controlled diet and have their blood pressure measured before and after four weeks of therapy. The goal is to find a more effective way to manage hypertension in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.